DK1083885T3 - Delavirdintabletformulering - Google Patents

Delavirdintabletformulering

Info

Publication number
DK1083885T3
DK1083885T3 DK99925951T DK99925951T DK1083885T3 DK 1083885 T3 DK1083885 T3 DK 1083885T3 DK 99925951 T DK99925951 T DK 99925951T DK 99925951 T DK99925951 T DK 99925951T DK 1083885 T3 DK1083885 T3 DK 1083885T3
Authority
DK
Denmark
Prior art keywords
delavirdine
tablet formulation
amount
superdisintegrant
binder
Prior art date
Application number
DK99925951T
Other languages
English (en)
Inventor
Walter Morozowich
Alice C Martino
Ashley H Bates
E John Lee
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22214517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1083885(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1083885T3 publication Critical patent/DK1083885T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
DK99925951T 1998-06-11 1999-06-07 Delavirdintabletformulering DK1083885T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8896098P 1998-06-11 1998-06-11
PCT/US1999/011798 WO1999063970A1 (en) 1998-06-11 1999-06-07 Delavirdine tablet formulation

Publications (1)

Publication Number Publication Date
DK1083885T3 true DK1083885T3 (da) 2007-02-26

Family

ID=22214517

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99925951T DK1083885T3 (da) 1998-06-11 1999-06-07 Delavirdintabletformulering

Country Status (21)

Country Link
US (3) US6177101B1 (da)
EP (1) EP1083885B1 (da)
JP (1) JP4827296B2 (da)
KR (2) KR100724016B1 (da)
CN (1) CN1237958C (da)
AT (1) ATE349203T1 (da)
AU (1) AU753241C (da)
BR (1) BR9910481A (da)
CA (1) CA2328703C (da)
CY (1) CY1105924T1 (da)
DE (1) DE69934582T2 (da)
DK (1) DK1083885T3 (da)
EA (1) EA004311B1 (da)
ES (1) ES2277682T3 (da)
HK (1) HK1036417A1 (da)
HU (1) HUP0102206A3 (da)
NZ (1) NZ508762A (da)
PL (1) PL200163B1 (da)
PT (1) PT1083885E (da)
WO (1) WO1999063970A1 (da)
ZA (1) ZA200006090B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004311B1 (ru) * 1998-06-11 2004-02-26 Фармация Энд Апджон Компани Таблетированная фармацевтическая композиция непролонгированного действия
AU784340B2 (en) 1999-12-23 2006-03-16 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US7115279B2 (en) 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
US20040243118A1 (en) * 2001-06-01 2004-12-02 Ayers Gregory M. Device and method for positioning a catheter tip for creating a cryogenic lesion
MXPA04001964A (es) * 2001-08-28 2004-06-07 Pharmacia Corp Base libre de clindamicina cristalina.
DE10164510A1 (de) 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
US20050163839A1 (en) * 2003-01-29 2005-07-28 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition containing metaxalone as active agent
JP2006522099A (ja) * 2003-04-04 2006-09-28 ファルマシア コーポレーション 複合粒状体からなる経口徐放性圧縮錠
US9241997B2 (en) 2003-06-13 2016-01-26 Idh Holding Aps Treatment of symptoms associated with bacterial vaginosis
CA2531116A1 (en) * 2003-07-01 2005-01-20 Michael Hawley Diffusion layer modulated solids
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050283146A1 (en) * 2004-06-17 2005-12-22 Lentz David J Thermally extended spiral cryotip for a cryoablation catheter
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US20070059359A1 (en) * 2005-06-07 2007-03-15 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
KR101190335B1 (ko) 2006-07-27 2012-10-11 가부시키가이샤 고베 세이코쇼 접속 장치 및 이 접속 장치를 통해 접속되는 혼련 장치와 구동 장치를 갖는 혼련 설비
CA2617688C (en) * 2007-02-22 2015-08-18 Alpex Pharma S.A. Solid dosage formulations containing weight-loss drugs
US8696606B2 (en) * 2009-09-28 2014-04-15 Continuous MotionFlow, LLC Passive motion machine with integrated mechanical DVT prophylactic therapy
EP3064064A1 (en) 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
US20120010216A1 (en) * 2010-07-06 2012-01-12 Brown Arthur M Pharmaceutical compositions containing vanoxerine
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9629841B2 (en) 2012-10-18 2017-04-25 Abbvie Inc. Formulations of pyrimidinedione derivative compounds
CN107595793B (zh) 2012-11-30 2020-11-13 阿库拉制药公司 活性药物成分的自调节释放
BR112015031027A2 (pt) 2013-06-13 2017-08-29 Akebia Therapeutics Inc Uso de um composto, método in vitro, composição farmacêutica e forma de dosagem única
EP3089757A1 (en) 2014-01-03 2016-11-09 AbbVie Inc. Solid antiviral dosage forms
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
JP2021523882A (ja) * 2018-05-15 2021-09-09 ジエンス ハンセン ファーマセウティカル グループ カンパニー リミテッド 低分子ｅｇｆｒ阻害剤を含む医薬組成物及びその製造方法
CN108619104A (zh) * 2018-06-29 2018-10-09 哈尔滨珍宝制药有限公司 一种基于盐酸克林霉素的药物组合物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
ZA855250B (en) * 1984-08-17 1986-02-26 Upjohn Co Stable,high dose,high bulk density ibuprofen granulations for tablet and capsule manufacturing
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
DE3708916A1 (de) 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
DE3868245D1 (de) * 1987-11-30 1992-03-12 Gist Brocades Nv Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
GB8824392D0 (en) * 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
CA2007764C (en) * 1989-02-24 1999-11-30 Joseph Michael Beaurline Salsalate tablet
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
ZA909847B (en) 1989-12-13 1992-08-26 Lilly Co Eli Glycopeptide derivatives
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
US5665720A (en) * 1992-08-07 1997-09-09 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2711524B1 (fr) * 1993-10-21 1995-11-24 Rhone Dpc Europ Procédé de préparation de compositions orales contenant des quinolones.
KR100364941B1 (ko) 1994-04-15 2003-02-19 파마시아 앤드 업존 캄파니 1-[5-메탄설폰아미도인돌릴-2-카보닐]-4-[3-(1-메틸에틸아미노)-2-피리디닐]피페라진의신규한결정형태
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5837292A (en) 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
UA72207C2 (uk) * 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
EA004311B1 (ru) * 1998-06-11 2004-02-26 Фармация Энд Апджон Компани Таблетированная фармацевтическая композиция непролонгированного действия

Also Published As

Publication number Publication date
CN1237958C (zh) 2006-01-25
US6177101B1 (en) 2001-01-23
KR20070040426A (ko) 2007-04-16
HK1036417A1 (en) 2002-01-04
CY1105924T1 (el) 2011-04-06
ES2277682T3 (es) 2007-07-16
DE69934582T2 (de) 2007-10-04
ATE349203T1 (de) 2007-01-15
ZA200006090B (en) 2001-10-29
AU753241C (en) 2003-05-08
EA004311B1 (ru) 2004-02-26
EA200100024A1 (ru) 2001-06-25
HUP0102206A3 (en) 2002-12-28
DE69934582D1 (de) 2007-02-08
EP1083885A1 (en) 2001-03-21
AU753241B2 (en) 2002-10-10
HUP0102206A2 (hu) 2002-03-28
JP2002517430A (ja) 2002-06-18
KR100724016B1 (ko) 2007-05-31
BR9910481A (pt) 2001-01-09
KR20010052717A (ko) 2001-06-25
JP4827296B2 (ja) 2011-11-30
EP1083885B1 (en) 2006-12-27
CA2328703C (en) 2007-10-30
CA2328703A1 (en) 1999-12-16
US20060257476A1 (en) 2006-11-16
PL344328A1 (en) 2001-10-22
PL200163B1 (pl) 2008-12-31
AU4213499A (en) 1999-12-30
US7108864B1 (en) 2006-09-19
PT1083885E (pt) 2007-01-31
CN1301149A (zh) 2001-06-27
NZ508762A (en) 2003-07-25
WO1999063970A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
ATE349203T1 (de) Delavirdin tablettenformulierung
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
GEP20012442B (en) Irreversible Inhibitors of Tyrosine Kinases
DK0730444T3 (da) Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol.
HUP0100072A3 (en) Phenoxazine, phenthiazine derivatives, their use in medicine; process for their preparation and pharmaceutical compositions containing them
ES2094359T3 (es) Formulaciones farmaceuticas de proteinas osteogenicas.
CA2346001A1 (en) Controlled release nanoparticulate compositions
DK74187A (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
ATE145132T1 (de) Therapeutische zusammensetzung und verfahren für ihre herstellung
ZA985392B (en) New derivatives of 2-(iminomethyl) amino-phenyl, their preparation their use as medicaments and the pharmaceutical compositions containing them
GEP20033062B (en) Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative
AU7239996A (en) Inhibition of tumor necrosis factor alpha
DE69632194D1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
TR200003303T2 (tr) Astıma, alerjiye, iltihaplanmaya karşı, bağışıklık düzenleyici ve sinirsel koruyucu etkiye sahip yeni 1,5- ve 3-O-ikameli 1H-indazoller, bunların hazırlanması ve tıbbi maddeler olarak kullanımları.
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
HK1024695A1 (en) Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
AU5139596A (en) Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
AU1606997A (en) Novel naphthylpiperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions and use thereof as drugs
GEU1998374Y (en) Method for Receiving Means for Treatment of Cardiovascular Diseases
HUP9901458A3 (en) Crystal form ii. of tazofelone, process for preparation thereof, use and pharmaceutical composition containing the same